AAAAAA
Results: 1-25/335
Authors:
YU D
Citation: D. Yu, SPONDYLOARTHROPATHIES - PREFACE, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 15-16
Authors:
VANDERLINDEN S
VANDERHEIJDE D
Citation: S. Vanderlinden et D. Vanderheijde, ANKYLOSING-SPONDYLITIS - CLINICAL-FEATURES, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 663
Authors:
AMOR B
Citation: B. Amor, REITERS-SYNDROME - DIAGNOSIS AND CLINICAL-FEATURES, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 677
Authors:
BRAUN J
BOLLOW M
SIEPER J
Citation: J. Braun et al., RADIOLOGIC-DIAGNOSIS AND PATHOLOGY OF THE SPONDYLOARTHROPATHIES, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 697
Authors:
LEIRISALOREPO M
Citation: M. Leirisalorepo, PROGNOSIS, COURSE OF DISEASE, AND TREATMENT OF THE SPONDYLOARTHROPATHIES, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 737
Authors:
LAU CS
BURGOSVARGAS R
LOUTHRENOO W
MOK MY
WORDSWORTH P
ZENG QY
Citation: Cs. Lau et al., FEATURES OF SPONDYLOARTHRITIS AROUND THE WORLD, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 753
Authors:
BANARES A
HERNANDEZGARCIA C
FERNANDEZGUTIERREZ B
JOVER JA
Citation: A. Banares et al., EYE INVOLVEMENT IN THE SPONDYLOARTHROPATHIES, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 771
Authors:
DEKEYSER F
ELEWAUT D
DEVOS M
DEVLAM K
CUVELIER C
MIELANTS H
VEYS EM
Citation: F. Dekeyser et al., BOWEL INFLAMMATION AND THE SPONDYLOARTHROPATHIES, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 785
Authors:
WARD MM
Citation: Mm. Ward, QUALITY-OF-LIFE IN PATIENTS WITH ANKYLOSING-SPONDYLITIS, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 815
Authors:
GLADMAN DD
Citation: Dd. Gladman, PSORIATIC-ARTHRITIS, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 829
Authors:
WORDSWORTH P
Citation: P. Wordsworth, GENES IN THE SPONDYLOARTHROPATHIES, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 845
PATHOGENESIS OF HUMAN-LEUKOCYTE ANTIGEN B27-POSITIVE ARTHRITIS - INFORMATION FROM CLINICAL MATERIALS
Authors:
MARKERHERMANN E
HOHLER T
Citation: E. Markerhermann et T. Hohler, PATHOGENESIS OF HUMAN-LEUKOCYTE ANTIGEN B27-POSITIVE ARTHRITIS - INFORMATION FROM CLINICAL MATERIALS, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 865
Authors:
KHARE SD
LUTHRA HS
DAVID CS
Citation: Sd. Khare et al., ANIMAL-MODELS OF HUMAN-LEUKOCYTE ANTIGEN B27-LINKED ARTHRITIDES, Rheumatic diseases clinics of North America, 24(4), 1998, pp. 883
Authors:
KREMER JM
Citation: Jm. Kremer, EMERGING THERAPIES FOR RHEUMATOID-ARTHRITIS - PREFACE, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 9-9
Authors:
ODELL JR
Citation: Jr. Odell, TRIPLE THERAPY WITH METHOTREXATE, SULFASALAZINE, AND HYDROXYCHLOROQUINE IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 465
Authors:
CRANNEY A
TUGWELL P
Citation: A. Cranney et P. Tugwell, THE USE OF NEORAL IN RHEUMATOID-ARTHRITIS, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 479
Authors:
ALARCON GS
Citation: Gs. Alarcon, MINOCYCLINE FOR THE TREATMENT OF RHEUMATOID-ARTHRITIS, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 489
Authors:
SMITH TJ
Citation: Tj. Smith, CYCLOOXYGENASES AS THE PRINCIPAL TARGETS FOR THE ACTIONS OF NSAIDS, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 501
Authors:
TRENTHAM DE
Citation: De. Trentham, ORAL TOLERIZATION AS A TREATMENT OF RHEUMATOID-ARTHRITIS, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 525
Authors:
WALLIS WJ
FURST DE
STRAND V
KEYSTONE E
Citation: Wj. Wallis et al., BIOLOGIC AGENTS AND IMMUNOTHERAPY IN RHEUMATOID-ARTHRITIS - PROGRESS AND PERSPECTIVE, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 537
Authors:
BREEDVELD FC
Citation: Fc. Breedveld, MONOCLONAL-ANTIBODIES TO CD4, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 567
Authors:
MORELAND LW
Citation: Lw. Moreland, SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR (P75) FUSION PROTEIN (ENBREL) AS A THERAPY FOR RHEUMATOID-ARTHRITIS, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 579
Authors:
KAVANAUGH AF
Citation: Af. Kavanaugh, ANTITUMOR NECROSIS FACTOR-ALPHA MONOCLONAL-ANTIBODY THERAPY FOR RHEUMATOID-ARTHRITIS, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 593
Authors:
BRESNIHAN B
CUNNANE G
Citation: B. Bresnihan et G. Cunnane, INTERLEUKIN-1 RECEPTOR ANTAGONIST, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 615
Authors:
KEYSTONE E
WHERRY J
GRINT P
Citation: E. Keystone et al., IL-10 AS A THERAPEUTIC STRATEGY IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, Rheumatic diseases clinics of North America, 24(3), 1998, pp. 629